Reaction Details Report a problem with these data
Target
5-hydroxytryptamine receptor 2A
Ligand
BDBM50352746
Substrate
n/a
Meas. Tech.
Binding Assay
pH
7.4±n/a
IC50
10.3±n/a nM
Comments
extracted
Citation
 Lee, J; Seo, HJ; Kang, SY; Park, E; Kim, MJ; Lee, SH; Kim, JY; Kim, J; Jung, ME; Kim, HJ; Kim, M; Han, HK; Ahn, KW; Lee, MW; Lee, K; Pae, AN; Park, W Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same US Patent  US8835436 Publication Date 9/16/2014 
Target
Name:
5-hydroxytryptamine receptor 2A
Synonyms:
5-HT-2 | 5-HT-2A | 5-HT2A | 5-hydroxytryptamine receptor 2A (5-HT-2A) | 5-hydroxytryptamine receptor 2A (5HT-2A) | 5-hydroxytryptamine receptor 2A (5HT2A) | 5HT2A_HUMAN | HTR2 | HTR2A | Serotonin receptor 2A
Type:
undefined
Mol. Mass.:
52607.65
Organism:
Homo sapiens (Human)
Description:
P28223
Residue:
471
Sequence:
MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV
  
Inhibitor
Name:
BDBM50352746
Synonyms:
CHEMBL1822902 | US8835436, Example 145
Type:
Small organic molecule
Emp. Form.:
C26H31Cl2N5O2
Mol. Mass.:
516.463
SMILES:
COc1ccccc1-n1c(C)nc(C(=O)NCCCN2CCN(CC2)c2cccc(Cl)c2Cl)c1C |(17.91,6.36,;17.91,4.82,;16.57,4.06,;15.24,4.83,;13.9,4.06,;13.9,2.51,;15.24,1.75,;16.56,2.52,;17.9,1.74,;18.37,.28,;17.46,-.96,;19.91,.28,;20.39,1.74,;21.72,2.51,;21.72,4.05,;23.06,1.74,;24.39,2.51,;25.73,1.74,;27.06,2.51,;28.39,1.75,;29.71,2.53,;31.04,1.76,;31.05,.22,;29.72,-.55,;28.37,.21,;32.38,-.54,;32.39,-2.08,;33.72,-2.84,;35.06,-2.07,;35.05,-.53,;36.38,.25,;33.71,.24,;33.71,1.78,;19.14,2.65,;19.14,4.19,)|
Structure:
Search PDB for entries with ligand similarity: